Colleagues from North Carolina State University and the Technical University of Denmark (DTU) will meet face to face at NC State Nov. 9–11, 2022, for the third annual Biopharmaceutical Manufacturing Symposium. Due to the pandemic, the first meeting was held virtually in 2020, while the 2021 symposium took place online with in-person meetings on each campus.
The annual Biopharmaceutical Manufacturing Symposium provides an opportunity for faculty, staff, and students participating in the program to meet, learn more about biomanufacturing, provide and receive updates on the program, and identify new opportunities for collaboration. During the symposium, which is by invitation only, participants will be able to attend poster sessions, lightning talks, NC State open houses, and question-and-answer sessions with guest speakers.
Day one of the meeting, which focuses on research and technology, will feature four separate keynote sessions. In addition, researchers will provide a quick overview of their projects in one-minute lightning talks, and further discussion will be possible during poster sessions. Also, short, moderated talks will be held on current topics, such as drug discovery, drug manufacturing, quality regulations, or product development.
The second day of the symposium will include an open house at NC State’s Centennial Campus and begin at the Biomanufacturing Training and Education Center (BTEC). Morning sessions will focus on the AIM-Bio continuing education program, which calls for the development of eight new professional development courses and the transfer of three of BTEC’s existing courses to DTU. The day’s program will include lightning talks and posters about the courses, followed by a tour of BTEC labs and simulated cGMP environment with demonstrations of AIM-Bio equipment. In the afternoon, participants will visit the AIM-Bio research labs for networking, discussion and problem solving. At the end of the day, participants will meet in groups for research ideation sessions.
The third day of the meeting will focus on research and possibilities for the future. The leadership committees for AIM-Bio’s three research groups — cell engineering research, process analytical technologies research, and single-use devices research — will report out to all symposium attendees. Following lunch, attendees will have the opportunity to participate in cultural activities in the Raleigh area. Representatives from the Novo Nordisk Foundation and members of the AIM-Bio External Advisory Board and the AIM-Bio Steering Committee will also meet on this final day.
Additional information about the symposium will be sent via email to AIM-Bio participants in coming weeks.